Translational imaging: Imaging of apoptosis

Handbook of Experimental Pharmacology

Volumn 185, Issue PART2, 2008, Pages 259-275

  Strauss, H William ^a   Blankenberg, Francis ^b   Vanderheyden, Jean Luc ^c   Tait, Jonathan ^d  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

^c GE HEALTHCARE   (United States)

^d UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; LIPOCORTIN 5; RADIOPHARMACEUTICAL AGENT;

ANIMAL; APOPTOSIS; CHEMISTRY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; GENETIC PROCEDURES; HUMAN; METABOLISM; METHODOLOGY; MOLECULAR PROBE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PINOCYTOSIS; POSITRON EMISSION TOMOGRAPHY; PROTEIN BINDING; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; ANNEXIN A5; APOPTOSIS; DIAGNOSTIC IMAGING; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; LIPIDS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR PROBE TECHNIQUES; MOLECULAR PROBES; PINOCYTOSIS; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 52049092529     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-540-77496-9_11     Document Type: Article

References (87)

1. Adebodun F, Chung J, Montez B, Oldfield E, Shan X (1992) Spectroscopic studies of lipids and biological membranes: carbon-13 and proton magic-angle sample-spinning nuclear magnetic resonance study of glycolipid-water systems.Biochemistry 31:4502-4509
2. Bazzi MD, Nelsestuen GL (1991) Highly sequential binding of protein kinase C and related proteins to membranes. Biochemistry. 30:7970-7977
3. Belhocine T, Steinmetz N, Hustinx R, Bartsch P, Jerusalem G, Seidel L, Rigo P, Green A (2002) Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. Clin Cancer Res 8:2766-2774
4. Belhocine T, Steinmetz N, Li C, Green A, Blankenberg FG (2004) The imaging of apoptosis with the radiolabeled annexin V: optimal timing for clinical feasibility. Technol Cancer Res Treat 3:23-32
5. Blankenberg FG (2003) Molecular imaging: The latest generation of contrast agents and tissue characterization techniques. J Cell Biochem 90:443-453
6. Blankenberg FG, Storrs RW, Naumovski L, Goralski T, Spielman D (1996) Detection of apoptotic cell death by proton nuclear magnetic resonance spectroscopy. Blood 87:1951-1956
7. Blankenberg FG, Katsikis PD, Storrs RW, Beaulieu C, Spielman D, Chen JY, Naumovski L, Tait JF (1997) Quantitative analysis of apoptotic cell death using proton nuclear magnetic resonance spectroscopy. Blood 89:3778-3786
8. Blankenberg FG, Katsikis PD, Tait JF et al (1998) In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci USA 95: 6349-6354
9. Blankenberg FG, Kalinyak J, Liu L, Koike M, Cheng D, Goris ML, Green A, Vanderheyden JL, Tong DC, Yenari MA (2006) 99mTc-HYNIC-annexin V SPECT imaging of acute stroke and its response to neuroprotective therapy with anti-Fas ligand antibody Eur J Nucl Med Mol Imaging 33:566-574
10. Boersma HH, Liem IH, Kemerink GJ, Thimister PW, Hofstra L, Stolk LM, van Heerde WL, Pakbiers MT, Janssen D, Beysens AJ, Reutelingsperger CP, Heidendal GA (2003) Comparison between human pharmacokinetics and imaging properties of two conjugation methods for 99mTc-annexin A5. Br J Radiol 76:553-560
11. Boersma HH, Stolk LM, Kenis H et al (2004) The ApoCorrect assay: a novel, rapid method to determine the biological functionality of radiolabeled and fluorescent Annexin A5. Anal Biochem 327:126-134
12. Boersma HH, Kietselaer BL, Stolk LM, Bennaghmouch A, Hofstra L, Narula J, Heidendal GA, Reutelingsperger CP (2005) Past, present, and future of annexin A5: from protein discovery to clinical applications. J Nucl Med 46:2035-2050
13. Bose S, Tuunainen I, Parry M, Medina OP, Mancini G, Kinnunena PKJ (2004) Binding of cationic liposomes to apoptotic cells. Anal Biochem 331:385-394
14. Bullok K, Piwnica-Worms D (2005) Synthesis and characterization of a small, membranepermeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis. J Med Chem 48:5404-5407
15. Cauchon N, Langlois R, Rousseau JA, Tessier G, Cadorette J, Lecomte R, Hunting DJ, Pavan RA, Zeisler SK, van Lier JE (2007) PET imaging of apoptosis with 64Cu-labeled streptavidin following pretargeting of phosphatidylserine with biotinylated annexin-V. Eur J Nucl Med Mol Imaging 34:247-258
16. Charles-Edwards EM, deSouza NM (2006) Diffusion-weighted magnetic resonance imaging and its application to cancer. Cancer Imaging 6:135-143
17. Cheng LL, Chang IW, Louis DN, Gonzalez RG (1998) Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens. Cancer Res 58:1825-1832
18. D'Arceuil H, Rhine W, de Crespigny A, Yenari M, Tait JF, Strauss WH, Engelhorn T, Kastrup A, Moseley M, Blankenberg FG (2000) 99mTc annexin V imaging of neonatal hypoxic brain injury. Stroke 31:2692-2700
19. Dekker B, Keen H, Shaw D et al (2005) Functional comparison of annexin V analogues labeled indirectly and directly with iodine-124. Nucl Med Biol 32:403-413
20. Deng J, Miller FH, Rhee TK, Sato KT, Mulcahy MF, Kulik LM, Salem R, Omary RA, Larson AC (2006) Diffusion-weighted MR imaging for determination of hepatocellular carcinoma response to ttrium-90 radioembolization. J Vasc Interv Radiol 17:1195-200
21. Emoto K, Kobayashi T, Yamaji A, Aizawa H, Yahara I, Inoue K, Umeda M (1996) Redistribution of phosphatidylethanolamine at the cleavage furrow of dividing cells during cytokinesis. Proc Natl Acad Sci U S A 93:12867-12872
22. Engelmann J, Henke J, WillkerW, Kutscher B, Nossner G, Engel J, Leibfritz D (1996) Early stage monitoring of miltefosine induced apoptosis in KB cells by multinuclear NMR spectroscopy. Anticancer Res 16(3B):1429-1439
23. Flotats A, Carrio I (2003) Non-invasive in vivo imaging of myocardial apoptosis and necrosis. Eur J Nucl Med Mol Imaging 30:615-630
24. Furukawa Y, Bangham CRM, Taylor GP, Weber JN, Osame M (2000) Frequent reversible membrane damage in peripheral blood B cells in human T cell lymphotrophic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Clin Exp Immunol 120: 307-316
25. Geske FJ, Lieberman R, Strange R, Gerschenson LE (2001) Early stages of p53-induced apoptosis are reversible. Cell Death Differ 8:182-191
26. Gottlieb RA (2005) Apoptosis. In: Lichtman MA, Beutler E, Kipps TJ, Seligsohn U, Kaushansky K, Prcha JT (eds) Williams Hematology, Part III: Molecular and cellular hematology, 7th edn. McGraw-Hill, pp 125-130
27. Grierson JR, Yagle KJ, Eary JF, Tait JF, Gibson DF, Lewellen B, Link JM, Krohn KA (2004) Production of [F-18]fluoroannexin for imaging apoptosis with PET. Bioconjug Chem 15: 373-379
28. Haas RL, de Jong D, Valdes Olmos RA, Hoefnagel CA, van den Heuvel I, Zerp SF, Bartelink H, Verheij M (2004) In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients. Int J Radiat Oncol Biol Phys 59:782-787
29. Haberkom U, Kinscherf R, Krammer PH, Mier W, Eisenhut M (2001) Investigation of a potential scintigraphic marker of apoptosis: radioiodinated Z-Val-Ala-DL-Asp(O-methyl)-fluoromethyl ketone. Nucl Med Biol 28:793-798
30. Hakumaki JM, Poptani H, Puumalainen AM, Loimas S, Paljarvi LA, Yla-Herttuala S, Kauppinen RA (1998) Quantitative 1H nuclear magnetic resonance diffusion spectroscopy of BT4C rat glioma during thymidine kinase-mediated gene therapy in vivo: identification of apoptotic response. Cancer Res 58:3791-3799
31. Hammill AK, Uhr JW, Scheuermann RH (1999) Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death. Exp Cell Res 251: 16-21
32. Hanshaw RG, Smith BD (2005) New reagents for phosphatidylserine recognition and detection of apoptosis. BioorgMed Chem 13:5035-5042
33. Jin M, Smith C, Hsieh HY, Gibson DF, Tait JF (2004) Essential role of B-helix calcium binding sites in annexin V-membrane binding. J Biol Chem 279:40351-40357
34. Kartachova M, Haas RL, Olmos RA, Hoebers FJ, van Zandwijk N, Verheij M (2004) In vivo imaging of apoptosis by 99mTc-annexin V scintigraphy: visual analysis in relation to treatment response. Radiother Oncol 72:333-339
35. Kemerink GJ, Liu X, Kieffer D, Ceyssens S, Mortelmans L, Verbruggen AM, Steinmetz ND, Vanderheyden J-L, Green A, Verbeke K (2003) Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application. J Nucl Med 44:947-952
36. Kenis H, van Genderen H, Bennaghmouch A, Rinia HA, Frederik P, Narula J, Hofstra L, Reutelingsperger CP (2004) Cell surface-expressed phosphatidylserine and annexin A5 open a novel portal of cell entry. J Biol Chem 279:52623-52629
37. Kerr JF (2002) History of the events leading to the formulation of the apoptosis concept. Toxicology 181-182:471-474
38. Kerr JFR, Searle JA (1972) A suggested explanation for the paradoxically slow growth of basal cell carcinomas that contain numerous mitotic figures. J Pathology 107:41-44
39. Kerr JF, Wylie AH, Currie AR (1972) Apoptosis: the basic biological phenomenon with wideranging implications in tissue kinetics. Brit J of Cancer 26:239-257
40. Kiestelaer BLJH, Reutelingsperger CPM, Heidendal GAK, Daemen MJAP, Mess WH, Hofstra L (2004) Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. New Engl J Med 350:1472-1473
41. Lahorte CM, van de Wiele C, Bacher K, van den Bossche B, Thierens H, van Belle S, Slegers G, Dierckx RA (2003) Biodistribution and dosimetry study of 123I-rh-annexin V in mice and humans. Nucl Med Commun 24:871-880
42. Lampl Y, Lorberboym M, Blankenberg FG, Sadeh M, Gilad R (2006) Annexin V SPECT imaging of phosphatidylserine expression in patients with dementia. Neurology 66:1253-1254
43. Laumonier C, Segers J, Laurent S, Michel A, Coppee F, Belayew A, Elst LV, Muller RN (2006) A New Peptidic Vector for Molecular Imaging of Apoptosis, Identified by Phage Display Technology. J Biomol Screen 11:537-545
44. Lejeune M, Ferster A, Cantinieaux B, Sariban E (1998) Prolonged but reversible neutrophil dyfunctions differentially sensitive to granulocyte colony-stimulating factor in children with acute lymphoblastic leukemia. Br J Haematol 102:1284-1291
45. Lidar Z, Mardor Y, Jonas T, Pfeffer R, Faibel M, Nass D, Hadani M, Ram Z (2004) Convectionenhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study. J Neurosurg 100:472-479
46. Lin SH, Vincent A, Shaw T, Maynard KI, Maiese K (2000) Prevention of nitric oxide-induced neuronal injury through the modulation of independent pathways of programmed cell death. J Cereb Blood Flow Metab 20:1380-1391
47. Lorberboym M, Blankenberg FG, Sadeh M, Lampl Y (2006) In vivo imaging of apoptosis in patients with acute stroke: correlation with blood-brain barrier permeability. Brain Res 1103: 13-19
48. Luo Q-Y, Zhang Z-Y, Wang F, Lu H-K, Guo Y-Z, Zhu R-S (2005) Preparation, in vitro and in vivo evaluation of 99mTc-Annexin B1: A novel radioligand for apoptosis imaging. Biochemical and Biophysical Research Communications 335:1102-1106
49. Lyng H, Sitter B, Bathen TF, Jensen LR, Sundfør K, Kristensen GB, Gribbestad IS (2007) Metabolic mapping by use of high-resolution magic angle spinning 1H MR spectroscopy predicts apoptosis in cervical carcinomas. BMC Cancer 7:11
50. Mahon MM, Williams AD, Soutter WP, Cox IJ, McIndoe GA, Coutts GA, Dina R, deSouza NM (2004) 1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration. NMR Biomed 17:1-9
51. Maiese K, Vincent AM (2000) Membrane asymmetry and DNA degradation: functionally distinct determinants of neuronal programmed cell death. J Neurosci Res 59:568-580
52. Martin S, Pombo I, Poncet P, David B, Arock M, Blank U (2000) Immunologic stimulation of mast cells leads to the reversible exposure of phosphatidylserine in the absence of apoptosis. Int Arch Allergy Immunol 123(3):249-258
53. Moka D, Vorreuther R, Schicha H, Spraul M, Humpfer E, Lipinski M, Foxall PJ, Nicholson JK, Lindon JC (1998) Biochemical classification of kidney carcinoma biopsy samples using magic-angle-spinning 1H nuclear magnetic resonance spectroscopy. J Pharm Biomed Anal 17: 125-132
54. Mukherjee A, Kothari K, Toth G, Szemenyei E, Sarma HD, Kornyei J, Venkatesh M (2006) 99mTc-labeled annexin V fragments: a potential SPECT radiopharmaceutical for imaging cell death.Nucl Med Biol 33(5):635-643
55. Murakami Y, Takamatsu H, Taki J, Tatsumi M, Noda A, Ichise R, Tait JF, Nishimura S (2004) 18F-labelled annexin V: a PET tracer for apoptosis imaging. Eur J Nucl Med Mol Imaging 31:469-474
56. Narula J, Strauss HW (2003) Invited commentary: P.S.? I love you: implications of phosphatidyl serine (PS) reversal in acute ischemic syndromes. J Nucl Med 44:397-399
57. Narula J, Acio ER, Narula N, Samuels LE, Fyfe B, Wood D, Fitzpatrick JM, Raghunath PN, Tomaszewski JE, Kelly C, Steinmetz N, Green A, Tait JF, Leppo J, Blankenberg FG, Jain D, Strauss HW (2001) Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat Med 7:1347-1352
58. O'Rourke MGE, Ellem KAO (2000) John Kerr and apoptosis. Med J Australia 173:616-617
59. Quinti L, Weissleder R, Tung C-H (2006) A fluorescent nanosensor for apoptotic cells. Nano Lett 6:488-490
60. Ran S, Downes A, Thorpe PE (2002) Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer Res 62:6132-6140
61. Riksen NP, Oyen WJ, Ramakers BP, Van den Broek PH, Engbersen R, Boerman OC, Smits P, Rongen GA (2005) Oral therapy with dipyridamole limits ischemia-reperfusion injury in humans. Clin Pharmacol Ther 78:52-59
62. Riksen NP, Zhou Z, Oyen WJ, Jaspers R, Ramakers BP, Brouwer RM, Boerman OC, Steinmetz N, Smits P, Rongen GA (2006) Caffeine prevents protection in two human models of ischemic preconditioning. J Am Coll Cardiol 48:700-707
63. Rongen GA, Oyen WJ, Ramakers BP, Riksen NP, Boerman OC, Steinmetz N, Smits P (2005) Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation 111:173-178
64. Rottey S, Slegers G, Van Belle S, Goethals I, Van de Wiele C (2006) Sequential 99mTchydrazinonicotinamide-annexin V imaging for predicting response to chemotherapy. J Nucl Med 47:1813-1818
65. Schellenberger EA, Weissleder R, Josephson L (2004a) Optimal modification of annexin V with fluorescent dyes. Chembiochem 5:271-274
66. Schellenberger EA, Sosnovik D, Weissleder R, Josephson L (2004b) Magneto/optical annexin V, a multimodal protein. Bioconjug Chem 15:1062-1067
67. Sosnovik DE, Schellenberger EA, Nahrendorf M, Novikov MS, Matsui T, Dai G, Reynolds F, Grazette L, Rosenzweig A, Weissleder R, Josephson L (2005) magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle. Magn Reson Med 54: 718-724
68. Stratton JR, Dewhurst TA, Kasina S, Reno JM, Cerqueira MD, Baskin DG, Tait JF (1995) Selective uptake of radiolabeled annexin V on acute porcine left atrial thrombi. Circulation 92: 3113-3121
69. Strauss HW, Narula J, Blankenberg FG (2000) Radioimaging to identify myocardial cell death and probably injury. Lancet 356:180-181
70. Tait JF, Cerqueira MD, Dewhurst TA, Fujikawa K, Ritchie JL, Stratton JR (1994) Evaluation of annexin V as a platelet-directed thrombus targeting agent. Thromb Res 75:491-501
71. Tait JF, Brown DS, Gibson DF, Blankenberg FG, Strauss HW (2000) Development and characterization of annexin V mutants with endogenous chelation sites for (99m)Tc. Bioconjug Chem 11:918-925
72. Tait JF, Gibson DF, Smith C (2004) Measurement of the affinity and cooperativity of annexin V-membrane binding under conditions of low membrane occupancy. Anal Biochem 329: 112-119
73. Tait JF, Smith C, Blankenberg FG (2005) Structural requirements for in vivo detection of cell death with 99mTc-annexin V. J Nucl Med 46:807-815
74. Taki J, Higuchi T, Kawashima A, Tait JF, Kinuya S, Muramori A, Matsunari I, Nakajima K, Tonami N, Strauss HW (2004) Detection of cardiomyocyte death in a rat model of ischemia and reperfusion using 99mTc-labeled annexin V. J Nucl Med 45:1536-1541
75. Thimister PW, Hofstra L, Liem IH, Boersma HH, Kemerink G, Reutelingsperger CP, Heidendal GA (2003) In vivo detection of cell death in the area at risk in acute myocardial infarction. J Nucl Med 44:391-396
76. Valonen PK, Lehtimaki KK, Vaisanen TH, Kettunen MI, Grohn OH, Yla-Herttuala S, Kauppinen RA (2004) Water diffusion in a rat glioma during ganciclovir-thymidine kinase gene therapy-induced programmed cell death in vivo: correlation with cell density. J Magn Reson Imaging 19:389-396
77. van deWiele C, Lahorte C, Vermeersch H, Loose D, Mervillie K, Steinmetz ND, Vanderheyden JL, Cuvelier CA, Slegers G, Dierck RA (2003) Quantitative tumor apoptosis imaging using technetium-99m-HYNIC annexin V single photon emission computed tomography. J Clin Oncol 21:3483-3487
78. van Tilborg GAF, Mulder WJM, Chin PTK, Storm G, Reutelingsperger CP, Nicolay K, Strijkers GJ (2006) Annexin A5-conjugated quantum dots with a paramagnetic lipidic coating for the multimodal detection of apoptotic cells. Bioconjugate Chem 17:865-868
79. Vermeersch H, Ham H, Rottey S, Lahorte C, Corsetti F, Dierckx R, Steinmetz N, Van de Wiele C (2004) Intraobserver, interobserver, and day-to-day reproducibility of quantitative 99mTc-HYNIC annexin-V imaging in head and neck carcinoma. Cancer Biother Radiopharm 19: 205-210
80. Vriens PW, Blankenberg FG, Stoot JH, Ohtsuki K, Berry GJ, Tait JF, Strauss HW, Robbins RC (1998) The use of technetium Tc 99m annexin V for in vivo imaging of apoptosis during cardiac allograft rejection. J Thorac Cardiovasc Surg 116:844-853
81. Wu XX, Arslan AA, Wein R, Reutlingsperger CP, Lockwood CJ, Kuczynski E, Rand JH (2006) Analysis of circulating Annexin A5 parameters during pregnancy: absence of differences between women with recurrent spontaneous pregnancy losses and controls. Am J Obstet Gyn 195:971-978
82. Wylie AH, Kerr JFR, Curry JR (1973) Cell death in the normal neonatal rat adrenal cortex. J Path 111:255-261
83. Yang MY, Chuang H, Chen RF, Yang KD (2002) Reversible phosphatidylserine expression on blood granulocytes related to membrane perturbation but not DNA strand breaks. J Leukoc Biol 71:231-237
84. Yang SK, Attipoe S, Klausner AP, Tian R, Pan D, Rich TA, Turner TT, Steers WD, Lysiak JJ (2006) In vivo detection of apoptotic cells in the testis using fluorescence labeled annexin V in a mouse model of testicular torsion. J Urol 176:830-835
85. Zhao M, Zhu X, Ji S, Zhou J, Ozker KS, FangW, Molthen RC, Hellman RS (2006) 99mTc-Labeled C2A Domain of synaptotagmin I as a target-specific molecular probe for noninvasive imaging of acute myocardial infarction. J Nucl Med 47:1367-1374
86. Zhou D, Chu W, Rothfuss J, Zeng C, Xu J, Jones L, Welch MJ, Mach RH (2006) Synthesis, radiolabeling, and in vivo evaluation of an 18F-labeled isatin analog for imaging caspase-3activation in apoptosis. Bioorg Med Chem Lett 16:5041-5046.
87. Zijlstra S, Gunawan J, Burchert W (2003) Synthesis and evaluation of a 18F-labelled recombinant annexin-V derivative, for identification and quantification of apoptotic cells with PET. Appl Radiat Isot 58:201-207